Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -181.30x is 36% below its 2-year average of -133.30x, near the low end of its 2-year range (-181.30x–-86.81x).
As of the fiscal period ended Sunday, December 31, 2023. 47.52% below its 12-month average of -122.89x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -181.30x.
INTEREST COVERAGE RATIO
-181.30x
INTEREST COVERAGE RATIO AVG TTM
-122.89x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-47.52%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
-2743.92%
vs the sector median at left
Xilio Therapeutics, Inc.
Market Cap
$60.49M
Interest Coverage Ratio
-181.30x
TTM Avg
-122.89x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$62.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$61.44M
Interest Coverage Ratio
-31.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.46M
Interest Coverage Ratio
-3392.06x
TTM Avg
18.65x
3Y Avg
15.79x
5Y Avg
19.13x
Market Cap
$59.41M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.16M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.16M
Interest Coverage Ratio
-58.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | $60.49M | -181.30x | -122.89x | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.21M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $62.69M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.44M | -31.98x | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $59.46M | -3392.06x | 18.65x | 15.79x | 19.13x |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.41M | N/A | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $58.16M | -5.91x | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | -58.65x | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.23M | -66.90x | N/A | N/A | N/A |
Interest Coverage
-181.3x
Debt/Equity
0.09
Current Ratio
4.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -181.30x |
| 2023-09-30 | -86.81x |
| 2023-06-30 | -100.58x |
| 2022-03-31 | -164.53x |
